We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Dermisonics Inc New (CE) | USOTC:DMSI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000025 | 0.00 | 01:00:00 |
1.
|
Check
the Appropriate Box if a Member of a Group (
See
Instructions)
|
(a)
|
o
|
(b)
|
o
|
|
Not
applicable.
|
2.
|
SEC
Use Only:
|
3.
|
Source
of Funds (See Instruction):
OO.
|
4.
|
Check
if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or
2(e):
o
|
|
Not
applicable.
|
5.
|
Citizenship
or Place of Organization:
Belize.
|
|
7.
|
Sole
Voting Power:
|
11,582,998
shares.
(1)
|
8.
|
Shared
Voting Power:
|
None
|
9.
|
Sole
Dispositive Power:
|
11,582,998
shares.
(1)
|
10.
|
Shared
Dispositive Power:
|
None
|
11.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person:
11,582,998
shares.
(1)
|
|
12.
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares
(
See
Instructions
):
o
|
|
|
Not
applicable.
|
13.
|
Percent
of Class Represented by Amount in Row (11):
18.6%.
(1),
(2)
|
|
14.
|
Type
of Reporting Person (
See
Instructions):
CO.
|
|
(1)
|
The
filing of this statement by the Reporting Person shall not be construed
as
an admission that the Reporting Person is, for the purposes of Section
13(d) or 13(g) of the Act, the beneficial owner of any securities
covered
by the statements herein.
|
(2)
|
Based
on 62,235,574 shares of common stock issued and outstanding as of
August
28, 2007.
|
A.
|
Names
of Persons filing this
Statement:
|
B.
|
Residence
or Business Address:
|
Newport
Capital Corp.
|
Brent Pierce: |
Rennweg
28
|
c/o Newport Capital Corp. |
Zurich,
Switzerland, CH-8001
|
Rennweg 28 |
Zurich, Switzerland, CH-8001 |
C.
|
Present
Principal Occupation and
Employment:
|
D.
|
Criminal
Proceedings:
|
E.
|
Civil
Proceedings:
|
F.
|
Citizenship:
|
|
(a)
|
the
acquisition by any person of additional securities of the Issuer,
or the
disposition of securities of the
Issuer;
|
|
(b)
|
any
extraordinary corporate transaction, such as a merger, reorganization
or
liquidation, involving the Issuer or any of its
subsidiaries;
|
|
(c)
|
a
sale or transfer of a material amount of the assets of the Issuer
or any
of its subsidiaries;
|
|
(d)
|
any
change in the present board of directors or management of the Issuer,
including any plans or proposals to change the number or term of
directors
or to fill any existing vacancies on the
board;
|
|
(e)
|
any
material change in the present capitalization or dividend policy
of the
Issuer;
|
|
(f)
|
any
other material change in the Issuer's business or corporate structure
including, but not limited to, if the Issuer is a registered closed-end
investment company, any plans or proposals to make
any
changes in its investment policy for which a vote is required by
Section
13 of the Investment Company Act of
1940;
|
|
(g)
|
changes
in the Issuer's charter, bylaws or instruments corresponding thereto
or
other actions which may impede acquisition of control of the Issuer
by any
person;
|
|
(h)
|
causing
a class of securities of the Issuer to be delisted from a national
securities exchange or to cease to be authorized to be quoted in
an
inter-dealer quotation system of a registered national securities
association;
|
|
(i)
|
a
class of equity securities of the Issuer becoming eligible for termination
of registration pursuant to Section 12(g)(4) of the Act;
or
|
|
(j)
|
any
action similar to any of those enumerated
above.
|
|
(a)
|
For
the purposes of this statement, the Reporting Person is reporting
herein
that as of the close of business on July 9, 2007 and to the date
hereof,
Newport Capital was the beneficial owner of 11,582,998
shares
(or approximately 18.6%) of the Issuer’s common stock. The
Board of Newport Capital has delegated to Mr. Pierce sole dispositive
and
voting power with respect to common shares owned by Newport
Capital.
|
|
(b)
|
For
the purposes of this statement, the Reporting Person is reporting
herein
that as of July 9, 2007 and to the date hereof, Newport Capital,
through
Mr. Pierce, had the sole power to vote or to direct the voting of,
or to
dispose or to direct the disposition of, 11,582,998
shares
(or approximately 18.6%) of the Issuer’s common
stock.
|
|
(c)
|
As
of July 9, 2007 and to the date hereof, and within the sixty day
period
prior thereto, to the best knowledge and belief of the undersigned,
no
transactions involving the Issuer’s equity securities had been engaged in
by Newport Capital or Mr. Pierce other than as disclosed
herein.
|
|
(d)
|
As
of July 9, 2007 and to the date hereof, to the best knowledge and
belief
of the undersigned, no person other than Newport Capital or Mr. Pierce
had
the right to receive or the power to direct the receipt of dividends
from,
or the proceeds from the sale of, the Issuer’s equity
securities.
|
|
(e)
|
Not
applicable.
|
NEWPORT CAPITAL CORP. | |||
Dated:
September 11, 2007
|
By:
|
/s/ Brent Pierce | |
Brent Pierce, President | |||
1 Year Dermisonics (CE) Chart |
1 Month Dermisonics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions